Mike Hollan is an assistant managing editor for Medical Device and Technology and Pharmaceutical Executive, and he can be reached at mhollan@mjhlifesciences.com.
Q&A With Hansa Bhargava, MD, Chief Medical Officer at Medscape Education
At the DTX Summit held in Washington DC on June 6-9, 2023, Dr. Hansa Bhargava participated in a panel discussion about putting the patient and provider first in the field of digital therapeutics. After the event, she sat with MD&T to further discuss how education around new therapies is impacting patients and providers.
Q&A With Craig Gravina, CTO at ObvioHealth
Clinical trials for digital therapeutics have unique problems when it comes to collecting data, especially regarding adherence and efficacy. Gravina speaks with MDT about a new API from ObvioHealth that works to solve these issues.
Whole-Person Care: Are We Ready? The Intersection of Pharma and Digital Therapeutics
Senior leaders focused on the advancement of digital medicine and health meet to discuss the importance of these tools for life sciences companies, payers, and others in harnessing a healthcare future that will be increasingly dominated by holistic treatment and delivery.